Results 191 to 200 of about 51,767 (241)

Clinical Utility of Serum Neurofilament Light Chain in Peripheral Neuropathy

open access: yesMuscle &Nerve, Volume 73, Issue 1, Page 86-92, January 2026.
ABSTRACT Introductions/Aims The clinical utility of serum neurofilament light chain (sNfL) in the evaluation and management of peripheral neuropathy (PN) remains poorly defined. This study aimed to evaluate the utility of sNfL for diagnosing PN, assessing disease activity, and monitoring treatment response using a commercially available assay.
Chafic Karam
wiley   +1 more source

New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System. [PDF]

open access: yesJ Clin Oncol
Khwaja J   +28 more
europepmc   +1 more source

Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA/ICOS risk score and other parameters [PDF]

open access: bronze
Daniela Di Lisi   +8 more
openalex   +1 more source

Longitudinal MRI Characterization of T1 and T2 Relaxation Times in an Amyloid Mouse Model of Alzheimer's Disease at 11.7 T

open access: yesNMR in Biomedicine, Volume 39, Issue 1, January 2026.
In this study, we systematically characterized the longitudinal evolution of T1 and T2 relaxation times at the early to middle stage of Tg2576 mouse model representing the amyloidosis subtype of Alzheimer’s disease. We found that rates of change in relaxation times within the thalamus, hypothalamus, and piriform cortex may serve as markers for ...
Soven Kumar   +4 more
wiley   +1 more source

Assessing Recurrent Acute Rhinosinusitis Development in Posttransplant Patients: A Study on Sinus Surgery Necessity

open access: yesOTO Open, Volume 10, Issue 1, January-March 2026.
Abstract Objective Recurrent acute rhinosinusitis (RARS) significantly decreases quality of life. Transplant recipients (TR) are particularly vulnerable to rhinologic conditions. There is a lack of guidelines for managing RARS in this population. Our study aims to determine the prevalence of and risk factors for RARS among TR and assess the need for ...
Estephania Candelo   +2 more
wiley   +1 more source

Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components

open access: yesSmall Methods, Volume 10, Issue 2, 22 January 2026.
The review presents a comprehensive overview of each component of lipid nanoparticles(LNPs)and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu   +6 more
wiley   +1 more source

Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis. [PDF]

open access: yesBr J Haematol
Khwaja J   +13 more
europepmc   +1 more source

Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management [PDF]

open access: gold
Areez Shafqat   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy